ClinVar Miner

Submissions for variant NM_024334.3(TMEM43):c.13T>C (p.Tyr5His)

gnomAD frequency: 0.00001  dbSNP: rs727505249
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000156770 SCV000206491 uncertain significance not specified 2014-08-21 criteria provided, single submitter clinical testing The Tyr5His variant in TMEM43 has not been previously reported in individuals wi th cardiomyopathy or in large population studies. Computational prediction tools and conservation analysis do not provide strong support for or against an impac t to the protein. This variant is located in the first base of the exon, which i s part of the 3? splice region. Computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pathoge nicity. In summary, the clinical significance of the Tyr5His variant is uncertai n.
Color Diagnostics, LLC DBA Color Health RCV001177858 SCV001342140 uncertain significance Cardiomyopathy 2024-05-23 criteria provided, single submitter clinical testing This missense variant replaces tyrosine with histidine at codon 5 of the TMEM43 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with TMEM43-related disorders in the literature. This variant has been identified in 1/250764 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Labcorp Genetics (formerly Invitae), Labcorp RCV001345124 SCV001539225 uncertain significance Arrhythmogenic right ventricular dysplasia 5 2024-08-28 criteria provided, single submitter clinical testing This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 5 of the TMEM43 protein (p.Tyr5His). This variant is present in population databases (rs727505249, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with TMEM43-related conditions. ClinVar contains an entry for this variant (Variation ID: 179967). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
All of Us Research Program, National Institutes of Health RCV001345124 SCV004841452 uncertain significance Arrhythmogenic right ventricular dysplasia 5 2024-06-09 criteria provided, single submitter clinical testing This missense variant replaces tyrosine with histidine at codon 5 of the TMEM43 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 1/250764 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
GeneDx RCV004777606 SCV005390719 uncertain significance not provided 2024-03-15 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.